Aastrom's stem cells in bone fracture promise
This article was originally published in Clinica
Executive Summary
Aastrom Biosciences' adult stem cell-based technology is showing promise as a treatment for long bone non-union fractures, according to additional interim data from a 36-patient, phase I/II multicentre clinical trial in the US.